The chapter “Studies in Medicine, Pharmaclogy, and Biology” of the LAS Yearbook 2022 includes four articles each dealing with a specific research topic in medicine, pharmacology, biology, as well as history of medicine.
“Current therapies can only delay, not halt neurodegenerative processes in the brain. Moreover, current therapies are only temporary effective, often cause unwanted side effects and about 30% of all patients do not respond to the therapy. Hence, there is an urgent necessity to find new approaches to design anti-neurodegenerative drugs, capable of stopping pathological events before dementia occurs, which in patients is a brief moment between mild cognitive impairment and the onset of dementia.” [Karīna Narbute, Vladimirs Piļipenko, Vija Zaiga Kluša. Is There a Light at the End of the Tunnel?]
“Our research has resulted in the discovery of unique, natural product inspired molecules which effectively kills breast and lung cancer cells without affecting normal healthy cells.” [Raivis Žalubovskis. A New Direction in the Development of Anti-cancer Drugs – the Construction of Special Molecules]
“Over the years, a large number of unique exhibits have been collected at Anatomicum. The very first collection contained about 2000 exhibits of natural material brought to Latvia by the first head of the Department of Anatomy, Swedish professor Gaston Backman (1883–1964).” [Māra Pilmane. THEATRUM ANATOMICUM RIGENSE and Their Historical Collections in the 20th Century]
“Pituitary neuroendocrine tumours (PitNETs) are nonmetastasising tumours of the pituitary gland with an overall estimated clinical prevalence affecting 1 in 400 to 1 in 1000 people. PitNETs are responsible for reduced quality of life and increased mortality.” [Vita Rovīte, Helvijs Niedra, Oļesja Rogoza, Līva Šteina. Research of Pituitary Neuroendocrine Tumors in Latvia, 2011–2021]